Affiliation:
1. Department of Endocrinology and Diabetes, Diabetes Treatment Center, Prince Sultan Military Medical City, P.O. Box
7897, Riyadh, 11159, Kingdom of Saudi Arabia
Abstract
Background::
Diabetes technology in the form of digital health or medical devices
holds a promise for improving the quality of life and glycemic outcomes. A comprehensive insight
into diabetes technology and its impact in Saudi Arabia and the MENA region may improve
type 1 diabetes mellitus (T1DM) management.
Objective::
his study aimed to assess the impact of different DM-specific technologies: insulin
pump therapy, continuous glucose monitoring (CGM), and automated insulin delivery system
in terms of glycemic control and QoL among T1DM patients in Saudi Arabia and the MENA
region.
Method::
A systematic literature search was performed in PubMed and Scopus from 2005 until
August 2023. The search was based on the PICO strategy, focusing on T1DM patients, diabetes
technology, and QoL. The inclusion criteria were studies illustrating the effect of diabetes technologies
on glycemic control or quality of life or both among T1DM patients. Systematic reviews,
books, letters, or studies, including type 2 diabetes mellitus, were excluded.
Results::
From 101 articles, eighteen studies were duplicated, and thirty-three studies were excluded
after reading the title and abstract. Of the 50 articles analyzed, twenty-five articles did
not meet the inclusion criteria. Therefore, 25 articles involving a total of 3088 participants were
enrolled in the study. It was shown that a continuous glucose monitoring system and continuous
subcutaneous insulin infusion improved the glycemic control and the QoL of T1DM patients.
Conclusion::
There was a positive impact of insulin pumps, continuous glucose monitoring
(CGM) systems, and telemedicine in achieving optimal glucose control and better QoL. Further
studies are recommended to clarify the significant role of advanced diabetes technologies.
Publisher
Bentham Science Publishers Ltd.